LY2510924 TFA salt - ≥99% , CAS No.1088715-84-7(free basis)

CAS: 1088715-84-7(free basis) Cat. No.: L414034 Molecular Weight: 1189.45(free basis)

GRADE & PURITY ≥99%

Synonyms

L-​Lysinamide,L-​phenylalanyl-​L-​tyrosyl-​N6-​(1-​methylethyl)​-​L-​lysyl-​D-​arginyl-​3-​(2-​naphthalenyl)​-​L-​alanylglycyl-​D-​α-​glutamyl-​N6-​(1-​methylethyl)​-​,(7→1)​-​lactam

Storage

Protected from light,Store at -20°C,Argon charged

Shipped In

Ice chest + Ice pads

Overview

Targets

CXCR4 (Cell-free) 0.079 nM

In vitro

In human lymphoma U937 cells expressing endogenous CXCR4, LY2510924 inhibits SDF-1-induced cell migration with IC50 value of 0.26 nmol/L and inhibits SDF-1/CXCR4-mediated intracellular signaling. LY2510924 exhibits a concentration-dependent inhibition of SDF-1-stimulated phospho-ERK and phospho-Akt in tumor cells. Biochemical and cellular analyses reveal that LY2510924 has no apparent agonist activity. LY2510924 has no inhibitory activities against other chemokine receptors including CCR1, CCR2, CXCR2, and CXCR3 at the concentrations tested. Similarly, there is no activity observed among serotonin, dopamine, and opioid receptors.

LY2510924 has acceptable in vivo stability and a pharmacokinetic profile similar to a typical small-molecular inhibitor in preclinical species. LY2510924 shows dose-dependent inhibition of tumor growth in human xenograft models developed with non-Hodgkin lymphoma, renal cell carcinoma, lung, and colon cancer cells that express functional CXCR4. In MDA-MB-231, a breast cancer metastatic model, LY2510924 inhibits tumor metastasis by blocking migration/homing process of tumor cells to the lung and by inhibiting cell proliferation after tumor cell homing. LY2510924 has a dramatically improved in vivo stability with a half-life of 3 to 5 hours in preclinical species and 9.16 hours in humans at the recommended phase II dose.

Cell Research(from reference)

Cell lines：U937 cells 

Incubation Time：2.5 h 

Specifications

Synonyms

L-​Lysinamide, L-​phenylalanyl-​L-​tyrosyl-​N6-​(1-​methylethyl)​-​L-​lysyl-​D-​arginyl-​3-​(2-​naphthalenyl)​-​L-​alanylglycyl-​D-​α-​glutamyl-​N6-​(1-​methylethyl)​-​, (7→1)​-​lactam

Specifications & Purity

≥99%

Biochemical and Physiological Mechanisms

LY2510924 is a potent and selective CXCR4 antagonist that specifically blocks SDF-1 binding to CXCR4 with IC50 value of 0.079 nmol/L and inhibits SDF-1-induced GTP binding with Kb value of 0.38 nmol/L.

Storage

Protected from light, Store at -20°C, Argon charged

Shipped In

Ice chest + Ice pads

This product requires cold chain shipping. Ground and other economy services are not available.

Action Type

INHIBITOR

Purity

≥99%

Names and Identifiers

• Molecular Weight: 1189.45(free basis)

Chemical and Physical Properties

• Solubility: Solubility (25°C) In vitro Water: 100 mg/mL (84.07 mM)
• Sensitivity: Light sensitive；Moisture sensitive